Clinical trials
Terminated Phase 3 trials in Hungary
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
378 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 4 |
| 2004 | 3 |
| 2005 | 17 |
| 2006 | 10 |
| 2007 | 13 |
| 2008 | 27 |
| 2009 | 15 |
| 2010 | 16 |
| 2011 | 23 |
| 2012 | 17 |
| 2013 | 17 |
| 2014 | 18 |
| 2015 | 15 |
| 2016 | 20 |
| 2017 | 23 |
| 2018 | 41 |
| 2019 | 21 |
| 2020 | 17 |
| 2021 | 28 |
| 2022 | 20 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 378 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 27 |
| Sanofi | 25 |
| Hoffmann-La Roche | 21 |
| Pfizer | 16 |
| GlaxoSmithKline | 12 |
| Amgen | 11 |
| AstraZeneca | 11 |
| Janssen Research & Development, LLC | 10 |
| Eli Lilly and Company | 7 |
| Gilead Sciences | 7 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 22 |
| Diabetes Mellitus, Type 2 | 19 |
| Crohn Disease | 12 |
| Diabetes Mellitus | 11 |
| Neoplasm Metastasis | 11 |
| Arthritis, Rheumatoid | 9 |
| Breast Neoplasms | 9 |
| Cardiovascular Diseases | 9 |
| Renal Insufficiency, Chronic | 9 |
| Alzheimer Disease | 8 |
Trials
Showing 1 to 25 of 378. Each trial links to its page on Pharma Observatory.
278 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.